Palestine Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Palestine Health Report.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on January 9, 2026

Jan. 9, 2026

Community Mental Health Association of Michigan Applauds Court of Claims Ruling on MDHHS Mental Health Bidout Process

GlobeNewswire

Jan. 9, 2026

ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research

GlobeNewswire

Jan. 9, 2026

Oncolytics Biotech® Outlines Strategic Rationale for Proposal to Change Jurisdiction of Incorporation to Nevada

GlobeNewswire

Jan. 9, 2026

Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026

GlobeNewswire

Jan. 9, 2026

Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Alamar Biosciences for the Transformative Bio-Hermes Studies

GlobeNewswire

Jan. 9, 2026

Senti Bio to Participate in Panel Presentation at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference

GlobeNewswire

Jan. 9, 2026

PDS Biotech Announces FDA Alignment on use of Progression Free Survival (PFS) as Primary Endpoint

GlobeNewswire

Jan. 9, 2026

Autonomix Showcases Compelling PoC Study Clinical Data Showing Rapid and Durable Pain Relief Across All Disease Stages of Pancreatic Cancer at the 2026 ASCO Gastrointestinal (GI) Cancers Symposium

GlobeNewswire

Jan. 9, 2026

CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC

GlobeNewswire

Jan. 9, 2026

Tenaya Therapeutics Announces 2026 Strategic Priorities and Anticipated Milestones

GlobeNewswire

Jan. 9, 2026

CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

Jan. 9, 2026

Lexicon Pharmaceuticals Publishes “Relief is Possible: Ensuring Access to Effective Treatments for Chronic Pain”

GlobeNewswire

Jan. 9, 2026

Clene Announces Registered Direct Offering of Over $28 Million

GlobeNewswire

Jan. 9, 2026

Cellectar Biosciences to Highlight Strategic Initiatives for 2026 at Upcoming Biotech Showcase during 44th Annual JP Morgan Healthcare Conference

GlobeNewswire

Jan. 9, 2026

Cartesian Therapeutics Highlights Recent Progress and Outlines 2026 Outlook

GlobeNewswire

Jan. 9, 2026

Madrigal Expands its MASH Pipeline with Exclusive Global License Agreement for Ervogastat, a Phase 2 Oral DGAT-2 Inhibitor

GlobeNewswire

Jan. 9, 2026

Medicines360 Acquires Global Licensing Rights to Innovative Maternal Health Technologies for Risk Identification and Management Throughout Pregnancy

GlobeNewswire

Jan. 9, 2026

NewAmsterdam Pharma Highlights 2025 Achievements and Outlines 2026 Strategic Priorities

GlobeNewswire

Jan. 9, 2026

Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery

GlobeNewswire

Jan. 9, 2026

Flare Therapeutics Appoints Stephen L. Eck, M.D., Ph.D., as Chief Medical Officer

GlobeNewswire